EC Number |
Inhibitors |
Structure |
---|
1.1.1.184 | (2E)-1-(2,4-dihydroxyphenyl)-3-(2',4',6-trihydroxy-5'-[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]biphenyl-3-yl)prop-2-en-1-one |
- |
|
1.1.1.184 | 1,10-phenanthroline |
- |
|
1.1.1.184 | 1,10-phenanthroline |
5 mM, 17% inhibition |
|
1.1.1.184 | 14,16-dihydroxy-3,8-dimethyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione |
zearalenone analogue |
|
1.1.1.184 | 18beta-glycyrrhetinic acid |
inhibits the reduction of bupropion in liver microsomes |
|
1.1.1.184 | 2,3,4-trinitrobenzenesulfonate sodium |
acts on a catalytic lysine located at the cofactor binding site, rapid inactivation of the liver enzyme, kinetics, NADP+, 2'-AMP, 2',5'-ADP, and 2'-phospho-5'-ADP-ribose partly protect, but 4-acetylpyridine, 5'-AMP, 5'-ADP, NMN and NAD+ do not |
|
1.1.1.184 | 2,3-Butanedione |
irreversible inactivation |
|
1.1.1.184 | 2,4-dinitrophenol |
- |
|
1.1.1.184 | 2,4-dinitrophenol |
19% inhibition at 0.1 mM |
|
1.1.1.184 | 2,4-dinitrophenol |
complete inhibition at 1 mM |
|